
zzso zzso is a zzso clinical event and is the primary cause of acute coronary syndromes and zzso intervention zzso zzso zzso There has been a long standing interest in the ex zzso zzso of zzso zzso to assess the risk of zzso Early studies demonstrated zzso zzso and heightened zzso zzso in acute coronary syndromes and after zzso However, a demonstration that heightened zzso actually zzso the zzso event was zzso Our knowledge of zzso zzso physiology and the advent of novel zzso have significantly advanced the zzso The zzso zzso has been shown to play a pivotal role in the amplification of zzso zzso by multiple zzso and its zzso has resulted in improved clinical zzso The most widely used drug to block zzso zzso zzso is associated with resistance in selected patients and these patients have been shown to be at increased risk for zzso zzso event occurrence in multiple zzso zzso a threshold of high zzso zzso has been demonstrated, and beyond this threshold zzso events occur zzso Based on the current evidence, it is rational to zzso the intensity of the zzso interaction in the patient at the greatest risk for zzso zzso zzso However, there is only evidence from small clinical trials demonstrating the clinical efficacy of changing an zzso regimen based on an ex zzso zzso function zzso Moreover, there are numerous patients with vulnerable coronary anatomy that have not yet experienced plaque zzso the zzso role of a measurement of zzso zzso in the latter group has never been zzso zzso trials are ongoing that will investigate the role of zzso zzso therapy in the zzso zzso 

